Enter your email address:

Delivered by FeedBurner

After Haryana's Anil Vij tests positive, Bharat Biotech says COVAXIN efficacious, safe

"COVAXIN clinical trials are based on a two-dose schedule, given 28
days apart. The vaccine efficacy will be determined 14 days after the
second dose. COVAXIN has been designed to be efficacious when subjects
receive both the doses," Bharat Biotech said in a statement. The
Haryana minister tested positive for novel coronavirus, around two
weeks after he was administered the first trial dose of Bharat biotech
vaccine candidate, COVAXIN.



Post a Comment